IRIS
IACCINO, Enrico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 663
EU - Europa 361
AS - Asia 37
SA - Sud America 3
OC - Oceania 2
Totale 1.066
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 636
IT - Italia 223
SE - Svezia 43
GB - Regno Unito 40
CA - Canada 27
DE - Germania 18
FR - Francia 10
IN - India 10
CN - Cina 9
JP - Giappone 6
KR - Corea 6
RU - Federazione Russa 5
UA - Ucraina 5
FI - Finlandia 3
PL - Polonia 3
RO - Romania 3
AT - Austria 2
CL - Cile 2
ES - Italia 2
GR - Grecia 2
HK - Hong Kong 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
BD - Bangladesh 1
BR - Brasile 1
MN - Mongolia 1
MY - Malesia 1
SG - Singapore 1
Totale 1.066
Salva come PNG Salva come JPEG
Città #
Chandler 142
Catanzaro 63
Lawrence 42
Princeton 42
Ashburn 35
London 35
Ottawa 27
Chicago 26
Wilmington 20
Napoli 16
Des Moines 10
Hanover 8
Seattle 6
Augusta 5
Naples 5
Redmond 5
Assago 4
Foggia 4
Latina 4
Luni 4
Norwalk 4
Paris 4
Providence 4
Rome 4
Seoul 4
Boston 3
Derby 3
Ferrara 3
Heiwajima 3
Helsinki 3
Huddinge 3
Novara 3
Redwood City 3
Reggio Calabria 3
Treviso 3
Adrano 2
Auckland 2
Bagnara Calabra 2
Chennai 2
Clearwater 2
Cosenza 2
Dianzicheng 2
Gallipoli 2
Genoa 2
Lowell 2
Milan 2
Modena 2
Montalto Uffugo 2
Nanchang 2
Pontedera 2
Portici 2
Pune 2
Romainville 2
Shanghai 2
Songpa-gu 2
Timisoara 2
Torre Del Lago 2
Torre del Greco 2
Vibo Valentia 2
Washington 2
Athens 1
Belgorod 1
Braga 1
Brecon 1
Cava Dei Tirreni 1
Dallas 1
Felgueiras 1
Fiumicino 1
Florence 1
Fremont 1
Gallneukirchen 1
Giarre 1
Guangzhou 1
Houston 1
Jülich 1
Kuala Lumpur 1
Las Vegas 1
Leawood 1
Los Angeles 1
Madrid 1
Marano 1
Montecorice 1
Mumbai 1
Munich 1
Reghin 1
Roccabernarda 1
Salerno 1
San Francisco 1
Stockholm 1
São Paulo 1
Troy 1
Turin 1
Ulaanbaatar 1
Urbino 1
Wuhan 1
Zgierz 1
Totale 639
Salva come PNG Salva come JPEG
Nome #
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 54
Phage display-derived peptides as tool for single B cell populations targeting in polyclonal CLL patients 37
Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtkγ. 34
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 32
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 32
Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations 31
Kitcre knock-in mice fail to fate-map cardiac stem cells 29
Isolation and Functional Characterization of Peptide Agonists of PTPRJ, a Tyrosine Phosphatase Receptor Endowed with Tumor Suppressor Activity. 29
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 28
Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces. 28
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 28
In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder 28
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 26
Critical role of zinc finger protein 521 in the control of growth, clonogenicity and tumorigenic potential of medulloblastoma cells. 25
Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors 25
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 24
Collagen type V polymorphism in spontaneous quadriceps tendon ruptures 24
Circulating microrna: The potential novel diagnostic biomarkers to predict drug resistance in temporal lobe epilepsy, a pilot study 24
A novel phage display based platform for exosome diversity characterization 24
Cancer-associated CD43 glycoforms as target of immunotherapy 24
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy 23
From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases 23
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 22
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 21
Insights into Thymus Development and Viral Thymic Infections 20
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival 20
The aftermath of the Merck's HIV vaccine trial 19
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 19
Phage-displayed peptides for targeting tyrosine kinase membrane receptors in cancer therapy 19
Phage Display: An Overview in Context to Drug Discovery 18
IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E- myc Mice 17
Insights about myc and apoptosis in b-lymphomagenesis: An update from murine models 17
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay 15
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 15
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 15
IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis 15
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 15
Expression of Serum Exosomal miRNA 122 and Lipoprotein Levels in Dogs Naturally Infected by Leishmania infantum: A Preliminary Study 14
Water soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor context 14
IBtkα Activates the β‐Catenin‐Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3βin Cancerous B Cells 14
Harnessing the potential of metalloproteinases in extracellular vesicles: a window of opportunity for aneurysm management 14
Identification of differentially expressed microRNAs in the skin of experimentally sensitized naturally affected atopic beagles by next-generation sequencing 13
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 13
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles 13
Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring 13
Thermoresponsive M1 macrophage-derived hybrid nanovesicles for improved in vivo tumor targeting 11
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 11
Elotuzumab plus Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 11
Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study 10
null 10
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 10
Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer's Disease 9
Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson's Disease 9
Peptide-guided targeting of GPR55 for anti-cancer therapy 9
Belantamab mafodotin in multiple myeloma 8
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 8
Diagnostic and therapeutic potential of exosomal miRNAs in Alzheimer's disease 8
Editorial: New perspectives on osteoclasts in health and disease 7
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials 7
Isatuximab in multiple myeloma 7
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 7
Elotuzumab in multiple myeloma 6
null 6
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells 1
Totale 1.162
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.819
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.819
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020103 0 0 0 15 15 1 5 11 5 6 9 36
2020/202195 4 6 2 4 7 1 12 2 31 19 0 7
2021/2022202 6 0 4 40 10 8 13 48 16 36 17 4
2022/2023471 87 34 29 21 42 38 13 30 85 27 48 17
2023/2024291 74 44 32 28 20 69 1 6 9 4 4 0
Totale 1.162